CHALLENGER LIMITED (CGF)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

CGF

CGF - CHALLENGER LIMITED

FNArena Sector : Wealth Management & Investments
Year End: June
GICS Industry Group : Diversified Financials
Debt/EBITDA: N/A
Index: ASX100 | ASX200 | ASX300 | ALL-ORDS

Challenger Ltd is an Australian financial company that specialises in superannuation and annuities. It claims to be Australia's largest guaranteed income provider. Founded in 1985 it was listed in 2003.

LAST PRICE CHANGE +/- CHANGE % VOLUME

$7.07

05 May
2025

-0.100

OPEN

$7.12

-1.39%

HIGH

$7.23

1,211,003

LOW

$7.05

TARGET
$7.423 5.0% upside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AEF . AMP . ASX . AVC . BVS . CVW . DJW . ENN . GDC . GDG . GQG . HMC . HUB . IFL . IFT . IRE . KAM . KSL . MAF . MFG . MQG . NGI . NWL . PAC . PNI . PPS . PPT . PTM . QAL . RPL . RZI . WHF .
FNARENA'S MARKET CONSENSUS FORECASTS
CGF: 1
Title FY23
Actual		 FY24
Actual		 FY25
Forecast		 FY26
Forecast
EPS (cps) xxx 19.0 57.8 xxx
DPS (cps) xxx 26.5 28.9 xxx
EPS Growth xxx - 55.0% 100.0% xxx
DPS Growth xxx 10.4% 8.9% xxx
PE Ratio xxx N/A 12.2 xxx
Dividend Yield xxx N/A 4.1% xxx
Div Pay Ratio(%) xxx 139.6% 50.0% xxx

Dividend yield today if purchased 3 years ago: 3.53%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 3.70

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/08 - ex-div 13.50c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx19.0
DPS All xxxxxxxxxxxxxxx26.5
Sales/Revenue xxxxxxxxxxxxxxx2,907.7 M
Book Value Per Share xxxxxxxxxxxxxxx568.0
Net Operating Cash Flow xxxxxxxxxxxxxxx843.7 M
Net Profit Margin xxxxxxxxxxxxxxx4.63 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx3.35 %
Return on Invested Capital xxxxxxxxxxxxxxx2.45 %
Return on Assets xxxxxxxxxxxxxxx0.42 %
Return on Equity xxxxxxxxxxxxxxx3.35 %
Return on Total Capital xxxxxxxxxxxxxxx11.14 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx692.4 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx5,593 M
Long Term Debt xxxxxxxxxxxxxxx1,532 M
Total Debt xxxxxxxxxxxxxxx7,126 M
Goodwill - Gross xxxxxxxxxxxxxxx580 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx573 M
Price To Book Value xxxxxxxxxxxxxxx1.23

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx1.9 M
Capex % of Sales xxxxxxxxxxxxxxx0.07 %
Cost of Goods Sold xxxxxxxxxxxxxxx-
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx828 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx31,000 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

7
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Morgan Stanley

xx/xx/xxxx

3

xxxxx-xxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Ord Minnett

22/04/2025

1

Buy

$8.00

13.15%

Challenger updated the market with a tightening of the FY25 guidance range for net profit, which suggests 10% growth on FY24, Ord Minnett explains.

The company also reported a more robust capital position than anticipated in the March quarter update, and the more upbeat tone came despite an annuity net outflow of -$180m and a decline in funds under management of -5%, due to market volatility.

The analyst notes sales of the retail lifetime product advanced by 22% due to a bigger contribution from its Japanese market distributors.

Buy rating reiterated due to potential changes in Australian retirement policies, which could make annuities a more attractive option, with an $8 target price.

Morgans

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Bell Potter

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

2

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Goldman Sachs

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Jarden

30/04/2025

2

Overweight

$7.50

6.08%

Challenger’s March quarter annuity sales and book growth missed Jarden's forecasts, although the tightening of FY25 normalised profit guidance has improved market confidence in management execution.

Despite softer retail and index-plus annuity sales, strength in longer-duration products and a robust capital ratio suggest improved resilience, with a positive rebalancing of the fixed income portfolio, explain the analysts.

The broker lowers FY26 EPS forecasts marginally but raises the target price to $7.50 from $7.40, citing lower balance sheet risks and a higher relative P/E multiple.

Challenger continues to trade at a -1-9% discount to its 10-year average multiple, supporting Jarden’s positive view despite macroeconomic risks. Overweight rating.

FORECAST
Jarden forecasts a full year FY25 dividend of 26.00 cents and EPS of 59.60 cents.
Jarden forecasts a full year FY26 dividend of 26.80 cents and EPS of 62.10 cents.
Access Extra Coverage Research History >

CGF STOCK CHART

FNArena News on CGF

1
Next Week At A Glance – 5-9 May 2025

May 02 2025 - Weekly Reports
2
Australian Broker Call *Extra* Edition – Apr 30, 2025

Apr 30 2025 - Daily Market Reports
3
Challenger’s Resilience Highlighted

Apr 28 2025 - Australia
4
Australian Broker Call *Extra* Edition – Apr 20, 2025

Apr 22 2025 - Daily Market Reports
5
Weekly Ratings, Targets, Forecast Changes – 21-03-25

Mar 24 2025 - Weekly Reports

Latest Wealth Management & Investments News

1
UBS Shines In A&NZ Equity Research Rankings

Apr 30 2025 - FYI
2
Family Offices; Australia’s Silent Wealth Revolution

Apr 30 2025 - SMSFundamentals
3
The Disappearance Of Financial Advisers In Oz

Apr 29 2025 - SMSFundamentals
4
Weekly Update On LICs & LITs – 29-Apr-2025

Apr 29 2025 - Weekly Reports
5
Challenger’s Resilience Highlighted

Apr 28 2025 - Australia
6
Weekly Update On LICs & LITs – 23-Apr-2025

Apr 23 2025 - Weekly Reports
7
Pinnacle Offers Buying Opportunity

Apr 22 2025 - Technicals
8
In Brief: Greatland Gold, Pinnacle, ResMed & Hub24

Apr 17 2025 - Weekly Reports
9
Weekly Update On LICs & LITs – 15-Apr-2025

Apr 15 2025 - Weekly Reports
10
Has Netwealth Been Punished Enough?

Apr 15 2025 - Australia